Related Experiment Videos
A role for calpain in optic neuritis
M Kelly Guyton1, Eric A Sribnick, Swapan K Ray
1Department of Microbiology/Immunology, Medical University of South Carolina, 96 Jonathan Lucus Street, Charleston, South Carolina 29425, USA.
Annals of the New York Academy of Sciences
|September 24, 2005
Summary
Calpain, a calcium-dependent protease, is implicated in optic neuritis (ON) development in experimental autoimmune encephalomyelitis (EAE) models. This suggests calpain may be a therapeutic target for neurodegenerative diseases like multiple sclerosis (MS).
Area of Science:
- Neuroimmunology
- Neurodegeneration
- Ophthalmology
Background:
- Optic neuritis (ON) is a primary symptom of multiple sclerosis (MS), a CNS neurodegenerative disease driven by immune attacks on myelin.
- Experimental autoimmune encephalomyelitis (EAE) serves as a key model for studying MS and ON, exhibiting demyelination, axonal damage, and neuronal loss.
- The precise mechanisms underlying neurodegeneration in EAE and MS remain incompletely understood.
Purpose of the Study:
- To review and synthesize existing evidence linking calpain activity to the pathogenesis of EAE-induced optic neuritis (EAE-ON).
- To explore the potential role of calpain as a contributing factor in neurodegeneration within the EAE model.
Main Methods:
- Review of existing literature and experimental data.
- Focus on studies utilizing the Lewis rat model of EAE.
- Analysis of evidence implicating calcium (Ca2+)-dependent neutral protease calpain.
Main Results:
- Evidence suggests a significant involvement of calpain in the development of EAE-ON.
- Calpain activity correlates with pathological changes observed in EAE-ON, including demyelination and neuronal damage.
- The study consolidates findings pointing to calpain as a key mediator in this disease model.
Conclusions:
- Calpain activation is strongly implicated in the neurodegenerative processes occurring during EAE-ON.
- These findings highlight calpain as a potential therapeutic target for mitigating neurodegeneration in MS and related conditions.
- Further research into calpain inhibition could offer novel treatment strategies for optic neuritis and multiple sclerosis.